ResearcherKanazawa Medical UniversityNo recent work listed

Hiroyuki Takamura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9351-1309; OpenAlex author ID A5101827581. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with … Co-author DOI 10.14670/hh-18-666 ↗
[Role of Surgical Resection after Chemoradiotherapy in Locally Advanced Pancreatic Cancer]. Last author PMID 33468742 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jia Han · 1 shared paper, 2023 · strength 0.16
- Paper The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival i… DOI 10.14670/hh-18-666 ↗
Sohsuke Yamada · 1 shared paper, 2023 · strength 0.16
- Paper The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival i… DOI 10.14670/hh-18-666 ↗
Michiyo Higashi · 1 shared paper, 2023 · strength 0.16
- Paper The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival i… DOI 10.14670/hh-18-666 ↗
Nobuhiko Ueda · 1 shared paper, 2021 · strength 0.12
- Paper [Role of Surgical Resection after Chemoradiotherapy in Locally Advanced Pancreatic Cancer]. PMID 33468742 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.